NM_000521.4:c.362A>G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000521.4(HEXB):​c.362A>G​(p.Lys121Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.185 in 1,611,362 control chromosomes in the GnomAD database, including 28,987 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3527 hom., cov: 32)
Exomes 𝑓: 0.18 ( 25460 hom. )

Consequence

HEXB
NM_000521.4 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.903

Publications

45 publications found
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
HEXB Gene-Disease associations (from GenCC):
  • Sandhoff disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Myriad Women’s Health, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a disulfide_bond (size 46) in uniprot entity HEXB_HUMAN there are 4 pathogenic changes around while only 1 benign (80%) in NM_000521.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0050745904).
BP6
Variant 5-74689390-A-G is Benign according to our data. Variant chr5-74689390-A-G is described in ClinVar as Benign. ClinVar VariationId is 3874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000521.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXB
NM_000521.4
MANE Select
c.362A>Gp.Lys121Arg
missense
Exon 2 of 14NP_000512.2P07686
HEXB
NM_001292004.2
c.-314A>G
5_prime_UTR
Exon 2 of 14NP_001278933.1Q5URX0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HEXB
ENST00000261416.12
TSL:1 MANE Select
c.362A>Gp.Lys121Arg
missense
Exon 2 of 14ENSP00000261416.7P07686
HEXB
ENST00000511181.5
TSL:1
c.-314A>G
5_prime_UTR
Exon 2 of 14ENSP00000426285.1Q5URX0
HEXB
ENST00000513079.5
TSL:2
n.427A>G
non_coding_transcript_exon
Exon 2 of 6

Frequencies

GnomAD3 genomes
AF:
0.208
AC:
31633
AN:
152046
Hom.:
3521
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.268
Gnomad AMI
AF:
0.307
Gnomad AMR
AF:
0.228
Gnomad ASJ
AF:
0.139
Gnomad EAS
AF:
0.152
Gnomad SAS
AF:
0.251
Gnomad FIN
AF:
0.174
Gnomad MID
AF:
0.168
Gnomad NFE
AF:
0.177
Gnomad OTH
AF:
0.201
GnomAD2 exomes
AF:
0.197
AC:
49605
AN:
251398
AF XY:
0.196
show subpopulations
Gnomad AFR exome
AF:
0.269
Gnomad AMR exome
AF:
0.251
Gnomad ASJ exome
AF:
0.142
Gnomad EAS exome
AF:
0.150
Gnomad FIN exome
AF:
0.169
Gnomad NFE exome
AF:
0.177
Gnomad OTH exome
AF:
0.191
GnomAD4 exome
AF:
0.183
AC:
266797
AN:
1459198
Hom.:
25460
Cov.:
30
AF XY:
0.184
AC XY:
133645
AN XY:
726094
show subpopulations
African (AFR)
AF:
0.278
AC:
9304
AN:
33416
American (AMR)
AF:
0.250
AC:
11196
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
3676
AN:
26122
East Asian (EAS)
AF:
0.165
AC:
6549
AN:
39686
South Asian (SAS)
AF:
0.243
AC:
20954
AN:
86180
European-Finnish (FIN)
AF:
0.167
AC:
8895
AN:
53412
Middle Eastern (MID)
AF:
0.168
AC:
967
AN:
5766
European-Non Finnish (NFE)
AF:
0.175
AC:
194077
AN:
1109586
Other (OTH)
AF:
0.185
AC:
11179
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
10770
21541
32311
43082
53852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6960
13920
20880
27840
34800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.208
AC:
31673
AN:
152164
Hom.:
3527
Cov.:
32
AF XY:
0.208
AC XY:
15501
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.268
AC:
11110
AN:
41500
American (AMR)
AF:
0.228
AC:
3479
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.139
AC:
481
AN:
3470
East Asian (EAS)
AF:
0.152
AC:
786
AN:
5166
South Asian (SAS)
AF:
0.251
AC:
1211
AN:
4826
European-Finnish (FIN)
AF:
0.174
AC:
1843
AN:
10598
Middle Eastern (MID)
AF:
0.173
AC:
51
AN:
294
European-Non Finnish (NFE)
AF:
0.177
AC:
12011
AN:
68002
Other (OTH)
AF:
0.200
AC:
422
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1268
2536
3805
5073
6341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
334
668
1002
1336
1670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.185
Hom.:
10610
Bravo
AF:
0.216
TwinsUK
AF:
0.177
AC:
656
ALSPAC
AF:
0.183
AC:
705
ESP6500AA
AF:
0.259
AC:
1141
ESP6500EA
AF:
0.169
AC:
1452
ExAC
AF:
0.199
AC:
24137
Asia WGS
AF:
0.227
AC:
789
AN:
3478
EpiCase
AF:
0.171
EpiControl
AF:
0.177

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Sandhoff disease (5)
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
HEXB POLYMORPHISM (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.056
DANN
Benign
0.33
Eigen
Benign
-2.4
Eigen_PC
Benign
-2.4
FATHMM_MKL
Benign
0.0035
N
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-0.90
T
PhyloP100
-0.90
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.35
N
REVEL
Benign
0.21
Sift
Benign
0.63
T
Sift4G
Benign
0.61
T
Vest4
0.011
MPC
0.14
ClinPred
0.0013
T
GERP RS
-7.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.29
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11556045; hg19: chr5-73985215; COSMIC: COSV54666892; COSMIC: COSV54666892; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.